What is Capricor Therapeutics's R&D?

Capricor Therapeutics (CAPR) reported R&D of $27.38M in Q1 2026.

How has Capricor Therapeutics's R&D changed year-over-year?

Capricor Therapeutics's R&D increased by 44.7% year-over-year, from $18.92M to $27.38M.

What is the long-term trend for Capricor Therapeutics's R&D?

Over 4 years (2021 to 2025), Capricor Therapeutics's R&D has grown at a 57.9% compound annual growth rate (CAGR), from $13.57M to $84.45M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Capricor Therapeutics CAPR R&D

R&D at other companies

PTC TherapeuticsPTCT

$100.87M-7.4%

Celldex TherapeuticsCLDX

$73M+38.7%

VericelVCEL

$8.1M+11.6%

Dyne Therapeutics, Inc.DYN

$100.89M-5.2%

Viridian Therapeutics, Inc.VRDN

$77.63M+1.0%

LeMaitre VascularLMAT

$4.06M-0.9%

Segments

By segment

See full

Single Reportable$27.38M+44.7%

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's R&D?: Capricor Therapeutics (CAPR) reported R&D of $27.38M in Q1 2026.
How has Capricor Therapeutics's R&D changed year-over-year?: Capricor Therapeutics's R&D increased by 44.7% year-over-year, from $18.92M to $27.38M.
What is the long-term trend for Capricor Therapeutics's R&D?: Over 4 years (2021 to 2025), Capricor Therapeutics's R&D has grown at a 57.9% compound annual growth rate (CAGR), from $13.57M to $84.45M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.